Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Pattern data conversion for lithography system
DKK1 oncogene as therapeutic target for cancer and a diagnosing marker
Method and apparatus for linking a web browser link to a promotional offer
Weighted determination in configuration management systems
System and method for generating profile morphing using cephalometric tracing data
Compositions and methods for concentrating and depleting microorganisms
Managing imaging of computing devices
  Randomly Featured Patents
Telephone stand
Heat exchanger for concentrating solar collectors and method for making the heat exchanger
Process for the protection of wood and coatings against deterioration by microorganisms
Thermoset epoxy polymers from renewable resources
Multiple material golf club head
Process for cobalt recovery from mixed sulfides
Grout sample unbonded capping system
Method of driving a light source, light source assembly for performing the method, and liquid crystal display apparatus having the same
Drawing pen having multiple side-matched absorptive drawing tips
Time dispersal encryption of TV signals